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.2013.01.0Abstract Status epilepticus (SE), one of the most severe forms of epilepsy is regarded a medical
emergency with considerable morbidity and mortality. Due to the limited efﬁcacy and enormous
side effects of currently available drugs, a search for new safe and effective therapeutic agents is crit-
ical using experimentally induced SE in animals. The lithium–pilocarpine (Li–Pc) model of SE is
most suitable and frequently used for pathophysiological and management strategies of SE. Recent
studies have shown signiﬁcant potential of pharmacological, prophylactic or therapeutic use of cur-
cumin (Cur) in many beneﬁcial activities in the body including neuroprotection in neurodegenera-
tive diseases and antioxidant properties. The present study describes anticonvulsive effects of Cur in
Li–Pc induced SE in young rats. The effect of Cur was examined on the intensity and frequency of
SE, cognitive behavior in water maze as well as on oxidative stress related enzymes in the brain.
Besides its anticonvulsant effect, Cur signiﬁcantly ameliorates SE-induced cognitive dysfunction
and oxidative damages in the hippocampus and striatum areas of the brain. Possible therapeutic
application of Cur as an anticonvulsant and as an antioxidant for the treatment of SE has a great
potential and warrants further studies.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
SE is a common neurological condition where recurrent gener-
alized convulsions last for more than 30 min and if not con-
trolled, neuronal injury occurs in the brain (Chen et al.,693625.
.
Saud University.
g by Elsevier
y. Production and hosting by Else
022010; Tariq et al., 2008). Neuronal hyperactivity during SE is
associated with a wide range of neurochemical imbalance in
some areas of the brain (Freitas et al., 2003, 2004; Tariq
et al., 2008). Such neuronal hyperactivity and/or excitotoxicity
have/has been associated with excessive generation of free rad-
icals (Bruce and Baudry, 1995; Freitas et al., 2005), particu-
larly in the brain, which contains large quantities of
oxidizable lipids and metals, and moreover, the brain has fewer
mechanisms of antioxidation than other tissues (Naffah-Mazz-
acoratti et al., 2001). There is ample evidence to suggest that
brain tissues are highly vulnerable to the oxidative stress
(Halliwell and Gutteridge, 1999; Freitas, 2009). SE induced
by Pc in rodent models can provide information regarding oxi-vier B.V. All rights reserved.
156 M. Ahmaddative stress-related epileptic activity (Freitas et al., 2003;
Smith and Shibley, 2002; Aboul Ezz et al., 2011; Du et al.,
2012). Besides epileptic seizure activities, oxidative stress has
also been related with cognitive impairment (Reeta et al.,
2009, 2010, 2011; Ataie et al., 2010). The anticonvulsant effect
of several agents having antioxidant properties such as vinea-
trol, transresveratrol, melatonin, adenosine, alpha lipoic acid,
pentoxifylline and buspirone, has been demonstrated in vari-
ous studies (Gupta and Briyal, 2006; Tariq et al., 2008; Freitas
et al., 2010). The Li–Pc model of SE reproduces most clinical,
temporal and neuropathological features of SE (Dube´ et al.,
2001; Tariq et al., 2008).
Curcumin (Cur) is a well known biologically active natural
compound (diferuoyl methane) found as a major component in
turmeric, a yellow curry spice, extracted from the rhizome of
Curcuma longa L. (family Zingiberaceae). Cur is well absorbed
and has exceedingly low toxicity (National Toxicology Pro-
gram, 1993). It possesses many beneﬁcial activities in the body
and is effective on several disorders including anorexia, coryza,
cough, hepatic diseases, and sinusitis (Rahman et al., 2006;
Tirkey et al., 2005). Recent studies provide scientiﬁc evidence
regarding the potential pharmacological, prophylactic or ther-
apeutic use of Cur, as anti-inﬂammatory, anticarcinogenic,
antitumoral, antiviral, antifungal, antiparasitic, antimutagen,
antiinfectious, antihepatotoxic and antioxidant compound
(Abdel-Latif and Sadek, 1999; Khanna, 1999; Park et al.,
2000; Chen et al., 2006; Ramsewak et al., 2000; Aggarwal
et al., 2007; Ciftci et al., 2010; Shehzad et al., 2011). Cur also
appears to be beneﬁcial in preventing diabetes-induced oxida-
tive stress in rats (Hussein and Abu-Zinadah, 2010). The multi-
ple beneﬁcial effects of Cur have also been elaborated in the
neurogenesis process which in turn has been reported for its
neuroprotective effects in age-related neurodegenerative dis-
eases (Cole et al., 2007). Several studies have shown that Cur
exhibits protective effects against oxidative damage and has
antioxidant and anticonvulsant properties exerting powerful
oxygen free radical scavenging effects and increased intracellu-
lar glutathione concentration, thereby protecting lipid peroxi-
dation (Kuhad et al., 2007; Kalpana et al., 2007; Reeta et al.,
2009, 2010, 2011; Ataie et al., 2010; Aboul Ezz et al., 2011; Cif-
tci et al., 2011a,b, 2012a,b; Du et al., 2012; Noor et al., 2012).
Commercial Cur contains 77% curcumin, 17% demethoxy
curcumin and 3% bisdemethoxy curcumin (Ahsan et al.,
1999) and virtually all these three components in Cur are bio-
logically active and possess protective properties (Jayapraka-
sha et al., 2006).
Inspite of the fact that around 50% of the cases of SE occur
in children younger than 2 years of age (Shinnar et al., 1997)
resulting in motor deﬁcits as well as learning and memory
problems (Hernandez et al., 2002), most of the experimental
studies related to epileptic seizures have been carried out in
adult animal models and the literature on young or immature
animal models is scarce (Nascimento et al., 2005; Tariq et al.,
2008). Studies related to Cur effects on Li–Pc induced seizures
in young models are scanty and need more attention. Although
recently, Du et al. (2012) reported anticonvulsive and antioxi-
dant effects of Cur in Pc-induced seizures in rat model, the
present study differs in many ways. Firstly, the model of in-
duced seizures used herein is Li–Pc and not only Pc. Secondly,
the present study has been carried out in young rats which are
much needed in seizure related studies. The present study was
therefore designed to evaluate the effect of Cur against Li–Pcinduced SE, cognitive dysfunction and oxidative stress in
young rats.
2. Materials and methods
2.1. Experimental animals
The animals used in the present study were young male Spra-
gue–Dawley rats (20 days old), and were housed under con-
trolled conditions with 12 h light–dark diurnal cycle at
22 ± 1 C, humidity at 50–60% and free access to food and
water except during experimental handlings. All study proto-
cols and experimental animal handling procedures were ap-
proved by the Review Committee and were in accordance
with the Research and Ethics Committee of King Saud Uni-
versity, Riyadh, Saudi Arabia.
2.2. Induction of status epilepticus (SE)
Animals were randomly assigned into eight groups. The ani-
mals in groups 1, 2, 3 and 4 served as controls and received sal-
ine, Li (3 mEq/ml/kg, i.p.), Pc (20 mg/ml/kg, s.c.) and DMSO
(50%), respectively. SE was induced in groups 5–8 by admin-
istering an aqueous (saline) solution of Li (BDH Laboratory
Supplies, Poole, England in a dose as in control), followed
by (20 h later) Pc (Sigma Chemical Co., St. Louis, MO,
USA, in the dose as used for control). Group 5 served as the
experimental control of SE group and groups 6–8 served as
the Cur test groups. Cur (Sigma, USA), was dissolved in
50% DMSO, and was administered at doses of 50, 100 and
200 mg/kg body weight/ml orally for three days prior to the
administration of Li and Pc as for the SE induction shown
above. After the Pc injections, the animals (n= 20 per group)
were observed for a sequence of behavioral alterations, includ-
ing peripheral cholinergic signs (PCS), stereotyped movements
(STM), clonic movements of forelimbs, head bobbing, tremors
and seizures, which developed progressively within 1–2 h into
SE (Persinger et al., 1993). All seizure activities were presented
as latencies to develop seizure and SE. Mortality (if any) with-
in 24 h, was also recorded.
2.3. Cognitive performance in Morris water maze
After induction of SE, the animals (n= 10 to 12 per group)
were subjected to cognitive behavioral studies over a period
of 6 days. Animals were allowed to acclimatize to the testing
room for 2 h before testing. All tests were performed between
10:00 and 15:00 h of the lighted phase. Morris water-maze test
has been extensively used to assess cognitive functions in a
variety of epilepsy models (Faverjon et al., 2002; Rutten
et al., 2002). Thus, the rats in the present study were tested
for visual-spatial memory performance using water-maze
(Morris, 1984). The water-maze consisted of a galvanized
white circular water tank (117 cm diameter, 55 cm height) ﬁlled
with clear tap water (26 ± 1 C) to a depth of 30 cm. A 10 cm
diameter, stainless steel, white, escape platform was placed
1 cm below the water level and the water was made opaque
by an addition of 1 l of milk, which prevented visualization
of the platform. Four points on the rim of the tank were des-
ignated north (N), south (S), east (E) and west (W), thus divid-
ing the pool into four quadrants (NW, NE, SE and SW).
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pool for 60 s without the platform present in the pool. This
free swim enabled the rat to become habituated to the training
environment. On days 2–5, rats were trained for 24 trials (six
trials a day, with an inter-trial interval of 30 s) to locate and
escape onto the submerged platform. At the start of each trial,
the rat was held facing the perimeter of the water tank and
dropped into the pool to ensure immersion. The latency from
immersion into the pool to escape onto the hidden platform
(maximum trial duration 120 s) was recorded. On mounting
the platform, each rat was given a 30 s inter-trial interval for
rest and for learning and memorizing the spatial cues to reach
the escape platform. The testing procedure used during the
four days of locating the hidden platform provides a measure
of hippocampal-dependent spatial reference memory (Spiers
et al., 2001).
On day 6, the rats were subjected to a 120 s probe trial in
which the platform was removed from the pool. The time spent
in each quadrant (within 120 s probe test) was recorded. In
such probe trials of water maze test, normal animals typically
spend more time in the quadrant where the platform had been
primarily located (days 2–5) than in other quadrants. Such
probe trial is a measure of the strength of spatial learning or
memory recall, the closest parallel to episodic memory in hu-
mans (Jeltsch et al., 2001).
2.4. Biochemical studies in brain tissue
Based on our pilot studies and literature survey (Freitas et al.,
2004; Nascimento et al., 2005; Freitas et al., 2006), biochemical
studies were undertaken 1 h after Li–Pc treatment. Immediately
after killing the animals (n= 8 from each group) by decapita-
tion, the brains were dissected on ice. The hippocampus and
striatum in the cerebral areas were removed and frozen in liquid
nitrogen and stored at70 C for determination of lipid perox-
ides (TBARS) and glutathione contents.
2.4.1. Determination of lipid peroxides
Lipid peroxides (LP) in the striatum and hippocampus were
determined spectrophotometrically as thiobarbituric acid-reac-
tive substances (TBARS) according to the method of Ohkawa
et al. (1979). The tissue samples were homogenized in 1.15%
cold KCl and after centrifugation at 3000g for 5 min, an aliquot
of supernatant was mixed with 2 ml of reaction mixture (con-
taining 15% trichloroacetic acid and 0.375% thiobarbituric
acid solution in 0.25 N HCl) and heated for 5 min in a boiling
water bath. The tubes were cooled at room temperature and
centrifuged at 1000g for 10 min. The absorbance of supernatant
was read at 535 nm against a blank that contained all reagents
except homogenate. Tissue lipid peroxide levels were quantiﬁed
using the extinction coefﬁcient of 1.5 x 105 m-1 cm-1 and ex-
pressed as nanomoles of TBARS formed per g tissue weight.
2.4.2. Determination of glutathione
Total glutathione (GSH) level in the striatum and hippocam-
pus was measured enzymatically in the brain tissues by a
slightly modiﬁed method of Mangino et al. (1991) as described
by Tariq et al. (1998). Brieﬂy, about 50 mg of isolated brain tis-
sues were homogenized with 1 ml 0.1 M perchloric acid plus
0.005% EDTA. The homogenates were centrifuged at
4000 rpm for 10 min and the supernatants were used forGSH assay. The reaction mixture consisted of the following
three freshly prepared solutions: solution I, 0.3 mM NADPH;
solution II, 6 mM 5,50-dithio-bis(2nitrobenzoic acid) and solu-
tion III, 50 U/ml glutathione (all chemicals from Sigma). All
three solutions were prepared with a stock buffer consisting
of 125 mM NaH2PO4 and 6.3 mM EDTA at pH 7.5. At the
time of glutathione assay, 800 ll of solution I, 100 ll of solu-
tion II, and 10 ll of solution III were mixed in a quartz cuvette
and placed in a dual beam UV–VIS spectrophotometer (Shi-
madzu UV160) at 30 C. The enzymatic reaction was started
by the addition of 100 ll of the supernatant and the absor-
bance was monitored for 3 min at 412 nm. The slope of the
change in absorbance was used to quantitate total GSH by
comparing the slope of the samples with a standard curve pre-
pared with pure glutathione (Sigma).
2.5. Statistical analysis
The data were analyzed by Bartlett’s test for equal variance and
by Gaussian-shaped distribution for normality using the Kol-
mogorov–Smirnov goodness-of-ﬁt test. As the data passed the
normality test (p> 0.10), group means were compared with
the ANOVA with post hoc testing using Tukey–Kramer Multi-
ple Comparisons Test or Student–Newman–Keuls Multiple
ComparisonsTests.All resultswere expressed asmeans ± SEM
and the signiﬁcance were deﬁned as p< 0.05 for all tests.
3. Results
3.1. Features of Li–Pc induced SE
All animals started developing a gradual and signiﬁcant change
in behavior including PCS (miosis, piloerection, diarrohea,
mild tremors, scratching, salivation) and STM (snifﬁng, paw
licking and rearing) within 5 min after injection of Pc, followed
by seizures in 100% of the animals with a mean latency of
9.84 ± 1.7 min to develop seizures (Table 1). The convulsive
episode consisted of head bobbing with intermittent forelimb
and hindlimb clonus, hyperextension of tails, loss of posture,
falling back and myoclonic jerks building up to a status epilep-
ticus (SE) in 100% of pups. The mean latency to onset of SE
was 24.52 ± 1.38 min (Table 1), and on the average, the SE
lasted for more than one hour. A total of 10% mortality was
observed over a period of 24 h following Pc injections (Table 1).
3.2. Effect of Cur pre-treatment on Li–Pc induced SE
Cur pretreatment dose-dependently increased the latency to sei-
zure and SE and decreased the percentage of seizures and SE
signiﬁcantly in a dose dependent manner (Table 1), and also re-
duced the intensity and frequency of seizure, PCS and STM epi-
sodes (not shown in Table 1). Furthermore, no mortality was
observed in the rats pretreated with Cur, as compared to
10% mortality in the Li–Pc treated (SE) group (Table 1). The
control groups did not show any signs of seizure or SE.
3.3. Cognitive performance in Morris water-maze test
Rats with Li–Pc treatment, exhibited longer escape latencies to
reach the platform as compared to control group (p< 0.01;
Table 1 Dose dependent antiepileptic activity of curcumin (Cur) against lithium–pilocarpine (Li–Pc) induced status epilepticus (SE) in
young rats.
Behavioral parameters observed Control Cur (mg/kg/ml)
0 50 100 200
Latency to seizures(min) 9.62 ± 1.20 12.46Ns ± 1.17 22.47a ± 1.59 35.33a+ ± 1.64
Seizures (%) 100 85.2 61.3a 21.3a
Latency to SE (min) 23.86 ± 1.54 32.52a ± 1.07 44.61a ± 1.22 56.11a ± 2.63
SE (%) 100 61.4a 36.8a 23.5a
Mortality (%)
within 24 h
10 0 0 0
Animals were observed for more than 1 h after Li–Pc injections for SE in all groups, and for more than 24 h for mortality.
Ns Statistically non signiﬁcant.
a p< 0.001 as compared to control (0 mg/kg/ml) by ANOVA followed by Student–Newman–Keuls multiple comparisons test.
158 M. AhmadFigure 1), however, all groups displayed a gradual improve-
ment in performance over the 4 days of testing (training)
period.
The probe trial studies showed that Cur treated animals
spent more time in the target (platform) quadrant as compared
to the Li–Pc only (SE) group (p< 0.001; Figure 2).1
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varying doses was effective in improving the cognitive function. Abb
epilepticus; # represents signiﬁcance as compared to control (p< 0.001
compared to SE group by ANOVA.3.4. Biochemical studies
3.4.1. Lipid peroxidation levels (TBARS) in the hippocampus
and striatum
The lipid peroxidation level (TBARS) in the hippocampus and
striatum were markedly (p< 0.001) increased after 1 h of2
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Figure 3 Effect of curcumin (Cur) on lipid peroxidation content (TBARS) in hippocampus (A) and striatum (B) of young rats after Li–
Pc induced SE. Abbreviations and statistical signiﬁcance are the same as in Figure 1.
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icantly (p< 0.001) and dose-dependently attenuated Li–Pc in-
duced increase in TBARS in the hippocampus and striatum as
compared to Li–Pc (SE) group (Figure 3).
3.4.2. Glutathione (GSH) in hippocampus and striatum
A highly signiﬁcant (p< 0.001) depletion of hippocampal and
striatal GSH was observed in Li–Pc (SE) group and pre-treat-
ment with Cur signiﬁcantly and dose-dependently attenuated
Li–Pc induced depletion in GSH as compared to Li–Pc (SE)
group (Figure 4).4. Discussion
The present ﬁndings demonstrate that Pc administration to rats
pretreated with Li, initiated cholinergic symptoms including
miosis, piloerection, diarrhea, mild tremors followed by sei-
zures. SE developed between 20 and 30 min after Pc adminis-
tration which consisted of head bobbing, intermittent
forelimb and hind limb clonus, hyperextension of tail and hind
limb along with loss of posture. The Morris water-maze results
showed that rats with SE took a longer time to reach the escape
platform or completely failed to reach the platform and spent
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Figure 4 Effect of curcumin (Cur) on total glutathione level (GSH) in hippocampus (A) and striatum (B) of young rats after Li–Pc
induced SE. Abbreviations and statistical signiﬁcance are the same as in Figure 1.
160 M. Ahmadless time in target quadrant, clearly suggesting for impaired vi-
sual-spatial memory and cognitive deﬁcit as suggested earlier
by other investigators (Wu et al., 2001; Tariq et al., 2008).
The present deﬁcits in cognitive ﬁndings of young rats are fur-
ther supported by clinical reports also where 33% intellectual
impairment have been reported in children with SE (Aicardi
and Chevrie, 1983). The speciﬁc cause of cognitive deteriora-
tion following SE is far from clear. However, according to re-
cent reports neurochemical imbalance and alteration of
neuronal structure following SE might be responsible for neu-
robehavioral changes (Kubova et al., 2004; Nascimento et al.,
2005; Rutten et al., 2002; Morris et al., 2003). The present bio-
chemical studies further indicated a signiﬁcant and dose-depen-
dent increase in TBARS and decrease in GSH levels in the
hippocampus and striatum of the rats treated with Li–Pc (Fig-
ures. 3 and 4) suggesting a preliminary and signiﬁcant level of
oxidative stress in these brain regions. Overactivation of excit-
atory amino acid receptors is an important pathogenic factor
that leads to seizure genesis and increased oxidative stress has
been implicated in the mechanisms of excitotoxicity-induced
neurodegeneration (Wang et al., 2004). It is pertinent to note
that neuronal loss and mossy ﬁber sprouting following SE have
been attributed to the excessive production of reactive oxygen
species (Ueda et al., 1997; Tariq et al., 2008).
The present results showed evidently the anticonvulsive
activity of Cur against Li–Pc induced seizure, as revealed by
highly signiﬁcant decrease in the frequency of epileptic epi-
sodes, increase in the latency to SE and no mortality (Table 1).
Thus, use of antioxidants could be a potential approach in
arresting or inhibiting the seizure genesis caused by excitotoxic
agents (Schulz et al., 1995).The phenolic yellow pigment Cur has potent antioxidant
activities (Calabrese et al., 2003; Kitani et al., 2004; Reeta
et al., 2009, 2010, 2011; Ataie et al., 2010; Aboul Ezz et al.,
2011; Du et al., 2012; Noor et al., 2012) and has shown a neu-
roprotective effect in models of cerebral ischemia (Ghoneim
et al., 2002; Thiyagarajan and Sharma, 2004), ethanol induced
brain damage (Rajakrishnan et al., 1999) and reduced amyloid
pathology in transgenic mice of Alzheimer’s disease (Lim et al.,
2001). In the present SE group, there was a signiﬁcant increase
in levels of TBARS and a signiﬁcant decrease in the levels of
GSH signifying oxidative stress in the hippocampus and stria-
tum areas of the brain. However, Cur pretreatment signiﬁ-
cantly and dose dependently attenuated Li–Pc induced OS
related enzymes disruption in the hippocampus and striatum
as compared to SE group (Figures. 3 and 4). Earlier studies
have also reported that Li–Pc disrupts the OS related enzymes
in these brain regions (Freitas et al., 2005; Xavier et al., 2007;
Tariq et al., 2008; Smith and Shibley, 2002; Freitas et al.,
2003). Thus it is likely that this pathomechanism may contrib-
ute at least in part to the pathophysiology of the seizure activ-
ity. The present study clearly suggests at a preliminary level
that Cur has promising anticonvulsant and antioxidant activi-
ties against SE in young rats. However, further studies on these
lines may be encouraging.Acknowledgement
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